Keith R. Edwards

7.2k total citations
101 papers, 2.9k citations indexed

About

Keith R. Edwards is a scholar working on Pathology and Forensic Medicine, Ecology and Plant Science. According to data from OpenAlex, Keith R. Edwards has authored 101 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 31 papers in Ecology and 22 papers in Plant Science. Recurrent topics in Keith R. Edwards's work include Multiple Sclerosis Research Studies (26 papers), Peatlands and Wetlands Ecology (24 papers) and Coastal wetland ecosystem dynamics (18 papers). Keith R. Edwards is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Peatlands and Wetlands Ecology (24 papers) and Coastal wetland ecosystem dynamics (18 papers). Keith R. Edwards collaborates with scholars based in United States, Czechia and Spain. Keith R. Edwards's co-authors include C. Edward Proffitt, Hana Šantrůčková, Steven E. Travis, Charles M. Poser, Susan B. Filskov, Janis M. Peyser, Tomáš Picek, Eva Kaštovská, Andrew Goodman and Hana Čı́žková and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Ecology.

In The Last Decade

Keith R. Edwards

97 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Keith R. Edwards 905 631 547 489 321 101 2.9k
Jonas Rastad 1.4k 1.6× 567 0.9× 1.2k 2.1× 104 0.2× 160 0.5× 229 9.9k
Antonio Ruggiero 260 0.3× 358 0.6× 555 1.0× 86 0.2× 65 0.2× 248 4.1k
Jean‐Christophe Leveque 467 0.5× 1.1k 1.7× 322 0.6× 47 0.1× 701 2.2× 138 5.0k
James R. Nelson 170 0.2× 800 1.3× 592 1.1× 446 0.9× 40 0.1× 78 3.9k
Vincenzo Di Stefano 226 0.2× 390 0.6× 455 0.8× 257 0.5× 29 0.1× 138 2.0k
Jurek Olszewski 234 0.3× 145 0.2× 487 0.9× 324 0.7× 54 0.2× 254 4.0k
John P. Anderson 117 0.1× 468 0.7× 1.5k 2.8× 175 0.4× 188 0.6× 95 6.0k
Scott R. Diehl 237 0.3× 89 0.1× 402 0.7× 268 0.5× 106 0.3× 84 4.4k
Kwang Soo Lee 299 0.3× 67 0.1× 175 0.3× 328 0.7× 137 0.4× 127 2.5k
Michael Arnold 304 0.3× 96 0.2× 404 0.7× 55 0.1× 497 1.5× 238 5.4k

Countries citing papers authored by Keith R. Edwards

Since Specialization
Citations

This map shows the geographic impact of Keith R. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith R. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith R. Edwards more than expected).

Fields of papers citing papers by Keith R. Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith R. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith R. Edwards. The network helps show where Keith R. Edwards may publish in the future.

Co-authorship network of co-authors of Keith R. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Keith R. Edwards. A scholar is included among the top collaborators of Keith R. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith R. Edwards. Keith R. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jakimovski, Dejan, Katelyn Kavak, David Hojnacki, et al.. (2022). COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections. Vaccines. 10(5). 695–695. 15 indexed citations
3.
Khayat-Khoei, Mahsa, Shamik Bhattacharyya, Joshua Katz, et al.. (2021). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of Neurology. 269(3). 1093–1106. 98 indexed citations
4.
Jakimovski, Dejan, Katelyn Kavak, Caila B. Vaughn, et al.. (2021). Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age. Multiple Sclerosis and Related Disorders. 57. 103406–103406. 18 indexed citations
5.
Middleton, Beth A., Steven E. Travis, Barbora Kubátová, Darren Johnson, & Keith R. Edwards. (2019). Morphology and genetics of Lythrum salicaria from latitudinal gradients of the Northern Hemisphere grown in cold and hot common gardens. PLoS ONE. 14(1). e0208300–e0208300. 6 indexed citations
6.
Edwards, Keith R., et al.. (2019). Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis. Multiple Sclerosis and Related Disorders. 31. 59–61. 11 indexed citations
7.
8.
Mellion, Michelle, Keith R. Edwards, Raymond Hupperts, et al.. (2017). Additional Efficacy Analyses from the Phase 2b SYNERGY Study Investigating the Anti-LINGO-1 Monoclonal Antibody Opicinumab for Treatment of Disabling Multiple Sclerosis (P5.337). Neurology. 88(16_supplement). 1 indexed citations
9.
Edwards, Keith R., et al.. (2017). Case report: Leukocytoclastic vasculitis in an MS patient following alemtuzumab treatment (P5.403). Neurology. 88(16_supplement). 5 indexed citations
10.
Coyle, Patricia K., Bhupendra Khatri, Keith R. Edwards, et al.. (2017). Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study. Multiple Sclerosis and Related Disorders. 17. 107–115. 32 indexed citations
11.
Fox, Edward, Keith R. Edwards, Daniel Wynn, et al.. (2014). Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 3(5). 607–619. 66 indexed citations
12.
13.
Edwards, Keith R., Jaya Goyal, Tatiana Plavina, et al.. (2013). Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis. PLoS ONE. 8(11). e81007–e81007. 32 indexed citations
14.
Kaštovská, Eva, et al.. (2010). Direct effect of fertilization on microbial carbon transformation in grassland soils in dependence on the substrate quality. Journal of Plant Nutrition and Soil Science. 173(5). 706–714. 12 indexed citations
15.
Goodman, Andrew, Theodore R. Brown, Keith R. Edwards, et al.. (2010). A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Annals of Neurology. 68(4). 494–502. 246 indexed citations
16.
Connor, Gregory S., Keith R. Edwards, & Daniel Tarsy. (2008). Topiramate in Essential Tremor. Clinical Neuropharmacology. 31(2). 97–103. 42 indexed citations
17.
Rowan, Elise, et al.. (2007). Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis. International Journal of Geriatric Psychiatry. 22(9). 890–895. 30 indexed citations
18.
Edwards, Keith R., Donald R. Royall, Linda A. Hershey, et al.. (2007). Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study. Dementia and Geriatric Cognitive Disorders. 23(6). 401–405. 64 indexed citations
19.
Grossberg, George T., Keith R. Edwards, & Qinying Zhao. (2006). Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease. The Journal of Clinical Pharmacology. 46(S1). 17S–26S. 41 indexed citations
20.
Edwards, Keith R., Barbara Koumaras, Michael Chen, İbrahim Günay, & Dario Mirski. (2005). Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing??Home Patients with Alzheimer???s Disease. Clinical Drug Investigation. 25(8). 507–515. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Rastad Breakdown of academic impact, for papers by Antonio Ruggiero Breakdown of academic impact, for papers by Jean‐Christophe Leveque Breakdown of academic impact, for papers by James R. Nelson Breakdown of academic impact, for papers by Vincenzo Di Stefano Breakdown of academic impact, for papers by Jurek Olszewski Breakdown of academic impact, for papers by John P. Anderson Breakdown of academic impact, for papers by Scott R. Diehl Breakdown of academic impact, for papers by Kwang Soo Lee Breakdown of academic impact, for papers by Michael Arnold
Rankless by CCL
2026